Exagen (XGN) Gross Profit (2018 - 2026)
Exagen filings provide 9 years of Gross Profit readings, the most recent being $10.2 million for Q1 2026.
- On a quarterly basis, Gross Profit rose 11.86% to $10.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was $39.9 million, a 18.56% increase, with the full-year FY2025 number at $38.8 million, up 17.18% from a year prior.
- Gross Profit hit $10.2 million in Q1 2026 for Exagen, up from $9.2 million in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $10.4 million in Q2 2025 to a low of $1.5 million in Q2 2022.
- Median Gross Profit over the past 5 years was $8.5 million (2024), compared with a mean of $7.8 million.
- Biggest five-year swings in Gross Profit: plummeted 79.13% in 2022 and later soared 443.26% in 2023.
- Exagen's Gross Profit stood at $6.5 million in 2022, then increased by 24.77% to $8.1 million in 2023, then rose by 4.08% to $8.5 million in 2024, then rose by 8.6% to $9.2 million in 2025, then rose by 10.85% to $10.2 million in 2026.
- The last three reported values for Gross Profit were $10.2 million (Q1 2026), $9.2 million (Q4 2025), and $10.1 million (Q3 2025) per Business Quant data.